Literature DB >> 18179390

The rise and fall of the common disease-common variant (CD-CV) hypothesis: how the sickle cell disease paradigm led us all astray (or did it?).

Oliver Mayo1.   

Abstract

The common disease-common variant (CD-CV) hypothesis requires an explanation for the origin of the variation observed, since substantial neutral, but not deleterious, variation, that is, several alleles each at moderate to high frequency, can be maintained at any gene/locus by mutation. It is argued here that the guiding principle, not always stated, has been balancing selection, influenced by the well-established cases of deleterious alleles maintained through heterozygous advantage in the face of strong malarial selection against normal alleles. It is further argued that, although balanced polymorphisms have indeed arisen and reduced population loss through infectious disease, the history of balance in other contexts should have prevented acceptance of any hypothesis that generalized such a specific mechanism. Finally, it is suggested that in the present state of knowledge no single hypothesis for the genetical contribution to common disorders is justifiable.

Entities:  

Mesh:

Year:  2007        PMID: 18179390     DOI: 10.1375/twin.10.6.793

Source DB:  PubMed          Journal:  Twin Res Hum Genet        ISSN: 1832-4274            Impact factor:   1.587


  5 in total

Review 1.  Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.

Authors:  Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2011-04       Impact factor: 4.246

2.  What is complex about complex disorders?

Authors:  Kevin J Mitchell
Journal:  Genome Biol       Date:  2012-01-23       Impact factor: 13.583

3.  Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder.

Authors:  I Jarick; A-L Volckmar; C Pütter; S Pechlivanis; T T Nguyen; M R Dauvermann; S Beck; Ö Albayrak; S Scherag; S Gilsbach; S Cichon; P Hoffmann; F Degenhardt; M M Nöthen; S Schreiber; H-E Wichmann; K-H Jöckel; J Heinrich; C M T Tiesler; S V Faraone; S Walitza; J Sinzig; C Freitag; J Meyer; B Herpertz-Dahlmann; G Lehmkuhl; T J Renner; A Warnke; M Romanos; K-P Lesch; A Reif; B G Schimmelmann; J Hebebrand; A Scherag; A Hinney
Journal:  Mol Psychiatry       Date:  2012-11-20       Impact factor: 15.992

4.  A genome-wide investigation of SNPs and CNVs in schizophrenia.

Authors:  Anna C Need; Dongliang Ge; Michael E Weale; Jessica Maia; Sheng Feng; Erin L Heinzen; Kevin V Shianna; Woohyun Yoon; Dalia Kasperaviciūte; Massimo Gennarelli; Warren J Strittmatter; Cristian Bonvicini; Giuseppe Rossi; Karu Jayathilake; Philip A Cola; Joseph P McEvoy; Richard S E Keefe; Elizabeth M C Fisher; Pamela L St Jean; Ina Giegling; Annette M Hartmann; Hans-Jürgen Möller; Andreas Ruppert; Gillian Fraser; Caroline Crombie; Lefkos T Middleton; David St Clair; Allen D Roses; Pierandrea Muglia; Clyde Francks; Dan Rujescu; Herbert Y Meltzer; David B Goldstein
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

5.  Rare Genomic Variants Link Bipolar Disorder with Anxiety Disorders to CREB-Regulated Intracellular Signaling Pathways.

Authors:  Berit Kerner; Aliz R Rao; Bryce Christensen; Sugandha Dandekar; Michael Yourshaw; Stanley F Nelson
Journal:  Front Psychiatry       Date:  2013-11-28       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.